Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Proof of Concept Pharmacokinetic/Pharmacodynamic Study of BXQ-350 in Cancer Patients Exposed to Oxaliplatin and/or Taxane-Based Chemotherapy

NCT05291286 is registered in ClinicalTrials.gov with Bexion Pharmaceuticals, Inc. as lead sponsor.

NCT NCT05291286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05291286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Proof of Concept Pharmacokinetic/Pharmacodynamic Study of BXQ-350 in Cancer Patients Exposed to Oxaliplatin and/or Taxane-Based Chemotherapy
Lead sponsor
Bexion Pharmaceuticals, Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 17, 2022
Completion date
December 20, 2024
Enrollment
21 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy, neuropathy;peripheral